Alexander Evgenyevich REPIK
Overview of Alexander Evgenyevich REPIK
ID | RUS1701 |
---|---|
Sanction Regime | The Russia (Sanctions) (EU Exit) Regulations 2019 |
Designation Source | UK |
Other Information | The Director Disqualification Sanction was imposed on 09/04/2025. |
Imposed Sanctions | Asset freeze, Travel Ban, Trust Services Sanctions |
Last Updated | Apr 09, 2025 |
UK Statement of Reasons | Alexander REPIK is an involved person within the meaning of the Russia (Sanctions) (EU Exit) Regulations 2019 because he is the Chairman of the Board of R-Pharm, one of Russia’s largest pharmaceutical companies. R-Pharm receives financing from the Russian Direct Investment Fund, meaning it is a Government of Russia-affiliated entity. Therefore, REPIK is the director or equivalent of an entity that is both carrying on business in a sector of strategic significance to the Government of Russia, namely, the chemicals sector, and carrying on business as a Government of Russia-affiliated entity. REPIK is also associated to an involved person in destabilising Ukraine, namely, President Putin, through his close working relationship with Putin. The trust services sanctions were imposed on 21/03/2023. |
OFSI Group ID | 15723 |
What alternative names has Alexander Evgenyevich REPIK used?
Name | Title | Name Type | Non-Latin Name | Alias Strength |
---|---|---|---|---|
Alexander Evgenyevich REPIK | Primary Name | Алексей Евгеньевич Репик (Russian / Cyrillic) | ||
Aleksey Evgenyevich REPIK | Primary Name Variation |
What are the personal details of Alexander Evgenyevich REPIK?
Gender | Date of Birth | Town of Birth | Country of Birth | Nationality | Passport | Position |
---|---|---|---|---|---|---|
Male | Aug 27, 1979 | Moscow | Russia | Russia 773105726303 | Chairman of the Board of R-Pharm, Chairman of Delovaya Rossiya |
Data Source
- The UK Sanctions List
A list maintained by the UK Government that identifies individuals and entities subject to financial sanctions. The list includes information on the reasons for the sanctions and the restrictions that apply. - license: CC0